ANI Pharmaceuticals, Inc.
ANIP
Price:
$82.74
Market Cap:
$1.86B
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2000-05-05
Stock Exchange
NASDAQ
Ticker
ANIP
PE Ratio
[51.71]
ROE
[-2.54%]
Current Ratio
[2.54]
Dividend Yield
[0%]
Enterprise Value
[1.96B]
Dividend History
The ROE as of December 2025 (TTM) for ANI Pharmaceuticals, Inc. (ANIP) is -2.54%
According to ANI Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -2.54%. This represents a change of 275.54% compared to the average of -0.68% of the last 4 quarters.
ANI Pharmaceuticals, Inc. (ANIP) Historical ROE (quarterly & annually)
How has ANIP ROE performed in the past?
The mean historical ROE of ANI Pharmaceuticals, Inc. over the last ten years is -1.57%. The current -2.54% ROE has changed 61.17% with respect to the historical average. Over the past ten years (40 quarters), ANIP's ROE was at its highest in in the March 2024 quarter at 3.82%. The ROE was at its lowest in in the June 2021 quarter at -7.35%.
Average
-1.57%
Median
0.85%
Minimum
-14.15%
Maximum
9.60%
ANI Pharmaceuticals, Inc. (ANIP) ROE by Quarter and Year
Discovering the peaks and valleys of ANI Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 19.13%
Maximum Annual ROE = 9.60%
Minimum Annual Increase = -1375.67%
Minimum Annual ROE = -14.15%
| Year | ROE | Change |
|---|---|---|
| 2024 | -4.32% | -205.32% |
| 2023 | 4.10% | -129.01% |
| 2022 | -14.15% | 19.13% |
| 2021 | -11.88% | 3.07% |
| 2020 | -11.52% | -502.32% |
| 2019 | 2.86% | -63.54% |
| 2018 | 7.85% | -1375.67% |
| 2017 | -0.62% | -126.55% |
| 2016 | 2.32% | -75.86% |
| 2015 | 9.60% | -53.30% |
ANI Pharmaceuticals, Inc. (ANIP) Average ROE
How has ANIP ROE performed in the past?
The current ROE of ANI Pharmaceuticals, Inc. (ANIP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.79%
5-year avg
-7.55%
10-year avg
-1.57%
ANI Pharmaceuticals, Inc. (ANIP) ROE vs. Peers
How is ANIP’s ROE compared to its peers?
ANI Pharmaceuticals, Inc.’s ROE is greater than Harrow Health, Inc. (-17.50%), greater than CanSino Biologics Inc. (-2.87%), greater than BGM Group Ltd. (-3.37%), greater than Tilray Brands, Inc. (-96.86%), less than Dermapharm Holding SE (17.61%), less than Hisamitsu Pharmaceutical Co., Inc. (7.23%), less than Green Thumb Industries Inc. (1.62%), less than Tsumura & Co. (8.71%), greater than Trulieve Cannabis Corp. (-13.25%), less than Fagron N.V. (17.09%),
| Company | ROE | Market cap |
|---|---|---|
| -17.50% | $1.73B | |
| -2.87% | $1.55B | |
| -3.37% | $1.48B | |
| -96.86% | $808.48M | |
| 17.61% | $2.13B | |
| 7.23% | $2.11B | |
| 1.62% | $1.59B | |
| 8.71% | $1.72B | |
| -13.25% | $1.19B | |
| 17.09% | $1.72B |
Build a custom stock screener for ANI Pharmaceuticals, Inc. (ANIP) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ANI Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
ANI Pharmaceuticals, Inc. (ANIP) and other stocks custom spreadsheet templates
The easiest way to analyze a company like ANI Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is ANI Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for ANI Pharmaceuticals, Inc. (ANIP)?
What is the highest ROE for ANI Pharmaceuticals, Inc. (ANIP)?
What is the 3-year average ROE for ANI Pharmaceuticals, Inc. (ANIP)?
What is the 5-year average ROE for ANI Pharmaceuticals, Inc. (ANIP)?
How does the current ROE for ANI Pharmaceuticals, Inc. (ANIP) compare to its historical average?